BioMerieux (XPAR:BIM) Price-to-Operating-Cash-Flow : 27.09 (As of Apr. 27, 2024)

View and export this data going back to 2004. Start your Free Trial

What is BioMerieux Price-to-Operating-Cash-Flow?

As of today (2024-04-27), BioMerieux's share price is €101.50. BioMerieux's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €3.75. Hence, BioMerieux's Price-to-Operating-Cash-Flow Ratio for today is 27.09.

The historical rank and industry rank for BioMerieux's Price-to-Operating-Cash-Flow or its related term are showing as below:

XPAR:BIM' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.86 Med: 20.51 Max: 41.01
Current: 26.9

During the past 13 years, BioMerieux's highest Price-to-Operating-Cash-Flow Ratio was 41.01. The lowest was 10.86. And the median was 20.51.

XPAR:BIM's Price-to-Operating-Cash-Flow is ranked worse than
67.24% of 116 companies
in the Medical Diagnostics & Research industry
Industry Median: 20.2 vs XPAR:BIM: 26.90

BioMerieux's Cash Flow from Operations per share for the six months ended in Dec. 2023 was €2.50. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €3.75.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of BioMerieux was -6.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -8.60% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 3.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 8.60% per year.

During the past 13 years, BioMerieux's highest 3-Year average Operating Cash Flow per Share Growth Rate was 27.10% per year. The lowest was -8.60% per year. And the median was 6.95% per year.

BioMerieux Price-to-Operating-Cash-Flow Historical Data

The historical data trend for BioMerieux's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMerieux Price-to-Operating-Cash-Flow Chart

BioMerieux Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

23.09

23.49

18.01

24.41

26.83

BioMerieux Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															18.01	-	24.41	-	26.83

Competitive Comparison of BioMerieux's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, BioMerieux's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioMerieux's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BioMerieux's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where BioMerieux's Price-to-Operating-Cash-Flow falls into.

BioMerieux Price-to-Operating-Cash-Flow Calculation

BioMerieux's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	101.50	/	3.747
	=	27.09

BioMerieux's Share Price of today is €101.50.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. BioMerieux's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €3.75.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

BioMerieux Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of BioMerieux's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

BioMerieux (XPAR:BIM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (XPAR:BIM) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

BMXMF:USA BIMp:UK 0RUG:UK EYWN:Germany BIM:Austria

Address

Marcy l’Etoile, Lyon, FRA, 69280

Website

http://www.biomerieux.com

BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about 17%). The Americas account for the largest portion of the firm's revenue (49%), followed by Europe, the Middle East, and Africa (33%), and Asia-Pacific (18%). BioMerieux is headquartered in Marcy-l'Etoile, France.

BioMerieux (XPAR:BIM) Headlines

No Headlines